Ergoteles LLC Rigel Pharmaceuticals Inc Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.67 - $3.19 $91,897 - $437,540	-137,160 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.22 - $3.45 $130,746 - $203,187	58,895 Added 75.25%	137,160 $410,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $184,705 - $279,406	78,265 New	78,265 $207,000
Q3 2021 Nov 15, 2021	SELL	$3.5 - $4.5 $92,400 - $118,800	-26,400 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.09 - $4.54 $81,576 - $119,856	26,400 New	26,400 $115,000

Q4 2020 Feb 11, 2021	SELL	$2.35 - $3.74 $54,990 - $87,516	-23,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $41,652 - $96,642	23,400 New	23,400 $56,000

122

110M

556K

33.9K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $1.42B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.